Additional file 6 of Targeting CD276 with Adapter-CAR T-cells provides a novel therapeutic strategy in small cell lung cancer and prevents CD276-dependent fratricide
Additional Table 1: Comprehensive list of the used antibodies with their respective fluorochrome, manufacturer, clone, dilution and identifier
Institutions
- Miltenyi Biotec (Germany) (DE)
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- University Hospital Regensburg (DE)
- Universitätsklinikum Tübingen (DE)
- Hopp Children's Cancer Center Heidelberg (DE)
- University Children's Hospital Tübingen (DE)
- Reutlingen University (DE)
- University of Tübingen (DE)
Publication Details
- Journal
- Figshare
- Published
- 2025-01-01
- DOI
- https://doi.org/10.6084/m9.figshare.29662497.v1
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00